Transarterial Chemoembolisation Combined With Lenvatinib Plus Pembrolizumab Versus Dual Placebo for Unresectable, Non-Metastatic Hepatocellular Carcinoma (LEAP-012): A Multicentre, Randomised, Double-Blind, Phase 3 Study
Durvalumab With or Without Bevacizumab With Transarterial Chemoembolisation in Hepatocellular Carcinoma (EMERALD-1): A Multiregional, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study
Appendicectomy Versus Antibiotics for Acute Uncomplicated Appendicitis in Children: An Open-Label, International, Multicentre, Randomised, Non-Inferiority Trial